SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $85,223 | +27.4% | 88,774 | -0.5% | 0.00% | – |
| Q1 2023 | $66,918 | +96.8% | 89,224 | -3.0% | 0.00% | – |
| Q4 2022 | $34,000 | +88.9% | 91,972 | +121.1% | 0.00% | – |
| Q3 2022 | $18,000 | -14.3% | 41,596 | +50.2% | 0.00% | – |
| Q2 2022 | $21,000 | -95.8% | 27,701 | -26.5% | 0.00% | -100.0% |
| Q1 2022 | $504,000 | +1192.3% | 37,708 | +24.1% | 0.00% | – |
| Q4 2021 | $39,000 | -42.6% | 30,382 | -3.6% | 0.00% | – |
| Q3 2021 | $68,000 | -57.2% | 31,503 | -26.0% | 0.00% | – |
| Q2 2021 | $159,000 | +127.1% | 42,559 | +101.9% | 0.00% | – |
| Q1 2021 | $70,000 | -10.3% | 21,077 | -7.9% | 0.00% | – |
| Q4 2020 | $78,000 | +2.6% | 22,880 | +23.5% | 0.00% | – |
| Q3 2020 | $76,000 | +261.9% | 18,528 | +195.8% | 0.00% | – |
| Q2 2020 | $21,000 | -78.4% | 6,264 | -85.1% | 0.00% | – |
| Q1 2020 | $97,000 | – | 42,017 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |